Belumosudil Yields Clinically Meaningful Outcomes in Patients With Chronic Graft-Vs-Host Disease
Researchers sough to determine whether belumosudil would help treat patients with chronic GVHD.
Graft Vs Host Disease
Anti-T Cell Lymphocyte Globulin Shows Similar Long-Term Outcomes to Post-Transplant Cyclophosphamide for GVHD Prophylaxis
Researchers sought to determine if GVHD prophylaxis with ATLG would be the same as PTCy in terms of long-term outcomes.
BAFF May Be Promising Therapeutic Target in Graft-Vs-Host Disease
Researchers sought to determine whether targeting BAFF and BCR pathways may improve outcomes in patients with chronic GVHD risk.
Low-Dose Anti-Thymoglobulin May Help Prophylaxis for Graft Vs Host Disease
Researchers sought to determine whether adding ATG would help improve prophylaxis for GVHD in patients with lymphoid malignancies.
Knowledge of Human Leukocyte Antigen Loss After Haploidentical Transplantation Helps Manage Patients With Hematologic Malignancies
Researchers sought to determine whether detecting HLA loss would be helpful in managing patients with hematologic malignancies who relapsed after haploidentical transplantation.
Risk Factors for Graft Rejection and Pediatric Hematopoietic Stem Cell Transplantation
Researchers sought to determine risk factors for graft rejection in pediatric patients receiving hematopoietic stem cell transplantation for bone marrow failure.
Alemtuzumab as Part of Conditioning Therapy for Graft-Vs-Host Disease in Children and Young Adults
Researchers sought to determine whether conditioning chemotherapy containing alemtuzumab may improve outcomes for GVHD in pediatric patients with hematologic malignancies.
AlloHCT Following Treatment With PD-1 mAbs Beneficial in Classic Hodgkin Lymphoma
An international, retrospective study was conducted to assess outcomes following alloHCT after PD-1 blockade in Hodgkin lymphoma.
Antibiotic Use Prior to Allogeneic Stem Cell Transplantation May Be Linked to Graft Vs Host Disease
Glycopeptide antibiotic therapy may be linked to risk of extensive chronic graft-versus-host disease after allogeneic stem cell transplantation.
Abatacept May Be Additional Prophylaxis for Graft-vs-Host Disease in Patients With Beta-Thalassemia
Researchers sought to determine whether adding abatacept to standard prophylaxis may reduce rates of GVHD in patients with beta-thalassemia.
- Loading...
Loading...
Next post in Thalassemias
Loading... 
Loading...